Journals / Klimik Dergisi / 2011 / Cilt: 24 - Sayı: 1

Prognostic value of procalcitonin in sepsis patients

Sepsisli hastalarda prokalsitoninin prognostik değeri

Pages
31–35
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: The results of the study showed that PCT can be used not only in the diagnosis of sepsis but also in predicting its prognosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The diagnostic and prognostic value of procalcitonin (PCT) was measured on different days in patients with sepsis.
📊
Key Findings & Data:Methods: 50 patients who were diagnosed with sepsis and followed up in intensive care units were included.
💡
Conclusion & Impact:Conclusions: The results of the study showed that PCT can be used not only in the diagnosis of sepsis but also in predicting its prognosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The diagnostic and prognostic value of procalcitonin (PCT) was measured on different days in patients with sepsis. Methods: 50 patients who were diagnosed with sepsis and followed up in intensive care units were included. Serum PCT levels of the patients with sepsis were measured before beginning of the antibacterial treatment, and then on third and fifth days. Results: Higher serum PCT levels were detected in the patients with sepsis. There was a significant statistical difference among the repeated measurements in the surviving patients. A statistical difference between surviving and nonsurviving patients were detected in patients with high risk and low risk in terms of their PCT levels. A significant difference was found between the PCT levels on day 1 and 5, especially in the survivors. Conclusions: The results of the study showed that PCT can be used not only in the diagnosis of sepsis but also in predicting its prognosis.

Özet

Amaç: Çalışmada sepsisli hastalarda farklı günlerde ölçülen prokalsitonin (PCT)in tanısal ve prognostik değeri araştırıldı. Yöntemler: Bu çalışmaya yoğun bakım ünitelerinde yatan sepsis tanısı konulmuş 50 hasta alındı. Sepsis tanısı alan hastaların birinci gün antibakteriyel tedavi başlamadan önce ve üçüncü ve beşinci günlerde serum PCT düzeyleri ölçüldü. Bulgular: Serum PCT düzeyi sepsis tanısı konulan hastalarda yüksek olarak bulundu. Sağ kalan hastalarda tekrarlayan ölçümler arasında anlamlı istatistiksel fark bulundu. Hastalar PCT düzeylerine göre yüksek riskli ve düşük riskli olarak iki gruba ayrıldığında, sağ kalan ve ölen hastalar arasında istatistiksel fark saptandı. Özellikle sağ kalan hastalarda birinci ve beşinci gün ölçülen PCT düzeyleri arasında anlamlı farklılık bulundu. Sonuçlar: Çalışmamızın sonuçlarına göre PCT sepsisli hastalarda sadece hastalığın tanısında değil, prognozunu belirlemede de kullanılabilir.

🔖

Cite This Article

GÜNAL, Ö., ERKORKMAZ, Ü., ULUTAN, F. (2022). Prognostic value of procalcitonin in sepsis patients. Klimik Dergisi, Cilt: 24 - Sayı: 1, 31–35. https://ajindex.com/articles/573677

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Alp E, Doğanay M. Sepsis: tanımlar. In: Arman D, Uzun Ö, eds. İnfeksiyon Hastalıklarında Tedavi Dizisi 7: Sepsis ve Tedavisi. Ankara: Bilimsel Tıp Yayınevi, 2004: 9-17. 2.Yorgancı K, Sayek İ. Sepsis ve ilgili tanımlamalar. Yoğun Bakım Derg. 2005
  2. 5(2): 75-9. 3.Matot I, Sprung CL. Definition of sepsis. Intensive Care Med. 2001
  3. 27(Suppl. 1): S3-9. [Crossref] 4.Meisner M. Procalcitonin (PCT). A New, Innovative Infection Parameter. Biochemical and Clinical Aspects. 3rd ed. Stuttgart: Thieme, 2000. 5.Carrol ED, Thomson AP, Hart CA. Procalcitonin as a marker of sepsis. Int J Antimicrob Agents. 2002
  4. 20(1): 1-9. [Crossref] 6.Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J. 2000
  5. 19(8): 679-87. [Crossref] 7.Maruna P, Nedelníková K, Gürlich R. Physiology and genetics of procalcitonin. Physiol Res. 2000
  6. 49(Suppl. 1): S57-61. 8.Oczenski W, Fitzgerald RD, Schwarz S. Procalcitonin: a new parameter for the diagnosis of bacterial infection in the peri-operative period. Eur J Anaesthesiol. 1998
  7. 15(2): 202-9. [Crossref] 9.Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985
  8. 13(10): 818-29. [Crossref] 10.Müller B, Becker LK, Schächinger H, et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med. 2000
  9. 28(4): 977-83. 11.de Bont ES, Vellenga E, Swaanenburg J, Kamps W. Procalcitonin: a diagnostic marker of bacterial infection in neutropenic cancer patients with fever? Infection. 2000
  10. 28(6): 398-400. 12.Fleischhack G, Cipic D, Juettner J, Hasan C, Bode U. Procalcitonin-a sensitive inflammation marker of febrile episodes in neutropenic children with cancer. Intensive Care Med. 2000
  11. 26(Suppl. 2): S202-11. [Crossref] 13.Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta. 2002
  12. 323(1-2): 17-29. [Crossref] 14.Friedman G, Silva E, Vincent JL. Has the mortality of septic shock changed with time. Crit Care Med.1998
  13. 26(12): 2078-86. [Crossref] 15.Demirdağ K, Özden M, Gödekmerdan A, Cihangiroğlu M, Kalkan A. Sepsis olgularında prokalsitonin, TNF-α ve C-reaktif protein düzeylerinin değerlendirilmesi. Klimik Derg. 2003
  14. 16(1): 21-4. 16.Kılınç O, Ece T, Arman D, et al. Türk Toraks Derneği erişkinlerde hastanede gelişen pnömoni tanı ve tedavi uzlaşı raporu. Türk Toraks Derg. 2009
  15. 10(Suppl. 6): 1-24. 17.Esen S, Leblebicioglu H. Prevalence of nosocomial infections at intensive care units in Tu